Pfizer said it would pay $86.25 per share in cash, a premium of 3.69% to Metsera’s Friday close.
Recent Posts
- Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
- Trump tells Senate Republicans to send federal health insurance money ‘directly to the people’
- Flight cancelations to worsen next week if shutdown continues
- Too early to bet against AI trade, State Street suggestsÂ
- Consumers on edge as ACA ‘subsidy cliff’ looms: ‘Quite frankly, it’s terrifying’